Salivary opiorphin levels in anorexia nervosa: A case–control study

References

• American Psychiatric Association. 2013. Diagnostic and statistical manual of mental disorders (DSM V). 5th ed. Washington (DC): APA.
   Google Scholar
• Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. 1961. An inventory for measuring depression. Arch Gen Psychiatry. 4:561–571.
   PubMed Web of Science ®Google Scholar
• Berrocoso E, Mico JA. 2009. Cooperative opioid and serotonergic mechanisms generate superior antidepressant-like effect in a mice model of depression. Int J Neuropsychopharmacol. 12:1033–1044.
   PubMed Web of Science ®Google Scholar
• Boucher Y, Braud A, Dufour E, Agbo-Godeau S, Baaroun V, Descroix V, Guinnepain MT, Ungeheuer MN, Ottone C, Rougeot C. 2017. Opiorphin levels in fluids of burning mouth syndrome patients: a case-control study. Clin Oral Investig. 21:2157–2164.
   PubMed Web of Science ®Google Scholar
• Braud A, Touré B, Agbo-Godeau S, Descroix V, Boucher Y. 2013. Characteristics of pain assessed with visual analog scale and questionnaire in burning mouth syndrome patients: a pilot study. J Orofac Pain. 27:235–242.
   PubMedGoogle Scholar
• Davies KP. 2009. The role of opiorphins (endogenous neutral endopeptidase inhibitors) in urogenital smooth muscle biology. J Sex Med. 6:286–291.
   PubMed Web of Science ®Google Scholar
• Douglas P, Dickinson MT. 1996. cDNA cloning of an abundant human lacrimal gland mRNA encoding a novel tear protein. Curr Eye Res. 15:377–386.
   PubMed Web of Science ®Google Scholar
• Dufour E, Villard-Saussine S, Mellon V, Leandri R, Jouannet P, Ungeheuer MN, Rougeot C. 2013. Opiorphin secretion pattern in healthy volunteers: gender difference and organ specificity. Biochem Anal Biochem. 2:2–11.
   Google Scholar
• International Headache Society Classification Committee. 2013. The International Classification of Headache disorders, 3rd edition (beta version.). Cephalalgia 33:629–808.
   PubMed Web of Science ®Google Scholar
• Jääskeläinen SK, Woda A. 2017. Burning mouth syndrome. Cephalalgia 37:627–647.
   PubMed Web of Science ®Google Scholar
• Javelot H, Messaoudi M, Garnier S, Rougeot C. 2010. Human opiorphin is a naturally occurring antidepressant acting selectively on enkephalin-dependent delta-opioid pathways. J Physiol Pharmacol. 61:355–362.
   PubMed Web of Science ®Google Scholar
• Kaye WH, Wierenga CE, Bailer UF, Simmons AN, Bischoff-Grethe A. 2013. Nothing tastes as good as skinny feels: the neurobiology of anorexia nervosa. Trends Neurosci. 36:110.
   PubMed Web of Science ®Google Scholar
• Haddadi NS, Foroutan A, Shakiba S, Afshar K, Ostadhadi S, Daneshpazhooh M, Dehpour AR. 2018. Attenuation of serotonin-induced itch by sumatriptan: possible involvement of endogenous opioids. Arch Dermatol Res. 310:165–172.
   PubMed Web of Science ®Google Scholar
• Levinson CA, Brosof LC, Vanzhula IA, Bumberry L, Zerwas S, Bulik CM. 2017. Perfectionism group treatment for eating disorders in an inpatient, partial hospitalization, and outpatient setting. Eur Eat Disorders Rev. 5:579–585.
   Google Scholar
• Lutz PE, Kieffer BL. 2013. Opioid receptors: distinct roles in mood disorders. Trends Neurosci. 36:195–206.
   PubMed Web of Science ®Google Scholar
• Mattar L, Huas C, Duclos J, Apfel A, Godart N. 2011. Relationship between malnutrition and depression or anxiety in Anorexia Nervosa: a critical review of the literature. J Affect Disord. 132:311–318.
   PubMed Web of Science ®Google Scholar
• Mattar L, Thiébaud MR, Huas C, Cebula C, Godart N. 2012. Depression, anxiety and obsessive–compulsive symptoms in relation to nutritional status and outcome in severe anorexia nervosa. Psychiatry Res. 200:513–517.
   PubMed Web of Science ®Google Scholar
• Meehan KG, Loeb KL, Roberto CA, Attia E. 2006. Mood change during weight restoration in patients with anorexia nervosa. Int J Eat Disord. 39:587–589.
   PubMed Web of Science ®Google Scholar
• Morley JE, Levine AS. 1982. The role of the endogenous opiates as regulators of appetite. Am J Clin Nutr. 35:757–761.
   PubMed Web of Science ®Google Scholar
• Paszynska E, Slopien A, Slebioda Z, Dyszkiewicz-Konwinska M, Weglarz M, Rajewski A. 2014. Macroscopic evaluation of the oral mucosa and analysis of salivary pH in patients with anorexia nervosa. Psychiatr Pol. 48:453–464.
   PubMed Web of Science ®Google Scholar
• Pollice C, Kaye WH, Greeno CG, Weltzin TE. 1997. Relationship of depression, anxiety, and obsessionality to state of illness in anorexia nervosa. Int J Eat Disord. 21:367–376.
   PubMed Web of Science ®Google Scholar
• Popik P, Kamysz E, Kreczko J, Wróbel M. 2010. Human opiorphin: the lack of physiological dependence, tolerance to antinociceptive effects and abuse liability in laboratory mice. Behav Brain Res. 213:88–93.
   PubMed Web of Science ®Google Scholar
• Rougeot C. 2014. U.S. Patent No. 8,889,827. Washington, DC: U.S. Patent and Trademark Office.
   Google Scholar
• Salaric I, Sabalic M, Alajbeg I. 2017. Opiorphin in burning mouth syndrome patients: a case-control study. Clin Oral Investig. 21:2363–2370.
   PubMed Web of Science ®Google Scholar
• Stanovic S, Boranic M, Petrovečki M, Batinic D, Skodlar J, Nemet D, Labar B. 2000. Thiorphan, an inhibitor of neutral endopeptidase/enkephalinase (CD10/CALLA) enhances cell proliferation in bone marrow cultures of patients with acute leukemia in remission. Haematologia 30:1–10.
   PubMedGoogle Scholar
• Thanawala V, Kadam VJ, Ghosh R. 2008. Enkephalinase inhibitors: potential agents for the management of pain. Curr Drug Targets 9:887–894.
   PubMed Web of Science ®Google Scholar
• Thornton LM, Trace SE, Brownley KA, Ålgars M, Mazzeo SE, Bergin JE, Maxwell M, Lichtenstein P, Pedersen NL, Bulik CM. 2017. A comparison of personality, life events, comorbidity, and health in monozygotic twins discordant for anorexia nervosa. Twin Res Hum Genet. 20:310–318.
   PubMed Web of Science ®Google Scholar
• Tian XZ, Chen J, Xiong W, He T, Chen Q. 2009. Effects and underlying mechanisms of human opiorphin on colonic motility and nociception in mice. Peptides 30:1348–1354.
   PubMed Web of Science ®Google Scholar
• Wisner A, Dufour E, Messaoudi M, Nejdi A, Marcel A, Ungeheuer MN, Rougeot C. 2006. Human Opiorphin, a natural antinociceptive modulator of opioid-dependent pathways. PNAS 103:17979–17984.
   PubMed Web of Science ®Google Scholar
• Wu M, Chen SW, Jiang SY. 2015. Relationship between gingival inflammation and pregnancy. Mediators Inflamm. 2015:623427.
   PubMed Web of Science ®Google Scholar
• Yang QZ, Lu SS, Tian XZ, Yang AM, Ge WW, Chen Q. 2015. The antidepressant-like effect of human opiorphin via opioid-dependent pathways in mice. Neurosci. Letters. 2015:1–135.
   Google Scholar
• Yim GK, Lowy MT. 1984. Opioids, feeding, and anorexias. Fed Proc. 43:2893–2897.
   PubMedGoogle Scholar